Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

UBS Maintains Buy on Bruker, Raises Price Target to $102

Author: Benzinga Newsdesk | March 01, 2024 12:36pm
UBS analyst John Sourbeer maintains Bruker (NASDAQ:BRKR) with a Buy and raises the price target from $94 to $102.

Posted In: BRKR

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist